Kyle Mikson News Today

In the preceding three months, 5 analysts have released ratings for Guardant Health (NASDAQ:GH), presenting a wide array of perspectives from bull...

Guardant Health (NASDAQ:GH) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The ...

During the last three months, 9 analysts shared their evaluations of Natera (NASDAQ:NTRA), revealing diverse outlooks from bullish to bearish. The...

Stock surged Wednesday after a jury said the DNA-testing company must pay competitor Ravgen $57 million in a patent lawsuit — significantly below the $410…

DNA sequencing company juggles leadership transition, questions about new product launch, and unwinding of a troubled acquisition

Operator: Good day and thank you for standing by. Welcome to the Quantum-Si Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Gene-sequencing company Illumina cuts its financial forecasts, prompting analysts to reduce their stock price targets.

Llumina, Inc. (NASDAQ: ILMN) shares are trading lower Friday after the company reported mixed third-quarter financial results on Thursday.

Operator: Thank you for standing by. My name is Aaron, and I will be your conference operator for today.